Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement

Publication
Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement
24 Apr 2020

 2020 Jul;75(7):1546-1554.

PMID: 32329930

PMCID: PMC7264744

DOI: 10.1111/all.14336

The current COVID‐19 pandemic influences many areas of social life, medical treatments and the way allergy is performed. Allergen‐specific immunotherapy (AIT) is one of the most important treatment options for IgE‐mediated allergies and is based on immunological effects on the diseased patient